Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
EN | CN

You are here:Home-Chemical Inhibitors & Agonists-PI3K/Akt/mTOR Pathway-PI3K-PI3Kβ inhibitor (P)-14
PI3Kβ inhibitor (P)-14

Chemical Structure : PI3Kβ inhibitor (P)-14

CAS No.: 2213418-22-3

PI3Kβ inhibitor (P)-14

Catalog No.: PC-20468Not For Human Use, Lab Use Only.

PI3Kβ inhibitor (P)-14 is a potent, highly selective and orally bioavailable PI3Kβ inhibitor with IC50 of 2 nM.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    PI3Kβ inhibitor (P)-14 is a potent, highly selective and orally bioavailable PI3Kβ inhibitor with IC50 of 2 nM.
    PI3Kβ inhibitor (P)-14 inhibits the phosphorylation of AKT (AKT1 ser473) in PTEN-deficient tumor cell lines with EC50 of 5-30 nM.

    Physicochemical Properties

    M.Wt 464.44
    Formula C25H14F2N8
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    4-[1-(5,8-Difluoro-4-quinolinyl)-2-methyl-4-(1H-1,2,4-triazol-5-yl)-1H-benzimidazol-6-yl]-2-pyridinecarbonitrile

    References

    1. Stephane Perreault, et al. ACS Med Chem Lett. 2020 Apr 13;11(6):1236-1243.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: